Financials (USD)
Sales 2024 * | 400K | Sales 2025 * | 250K | Capitalization | 37.64M |
---|---|---|---|---|---|
Net income 2024 * | -32M | Net income 2025 * | -40M | EV / Sales 2024 * | 94.1 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 151 x |
P/E ratio 2024 * |
-3.3
x | P/E ratio 2025 * |
-3.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.62% |
Latest transcript on Foamix Pharmaceuticals Ltd.
Managers | Title | Age | Since |
---|---|---|---|
David Domzalski
CEO | Chief Executive Officer | 58 | 20-02-29 |
Tyler Zeronda
DFI | Director of Finance/CFO | 38 | - |
Iain Stuart
CTO | Chief Tech/Sci/R&D Officer | 51 | 20-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Pat LePore
BRD | Director/Board Member | 69 | 20-09-09 |
Steven Basta
BRD | Director/Board Member | 59 | 14-12-31 |
Anthony Bruno
BRD | Director/Board Member | 68 | 20-02-29 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+29.55% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.19% | 240B | |
+9.45% | 208B | |
-7.16% | 200B | |
+7.68% | 166B |